Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22689642 | 1.00 | CA2 (0.33) | CA2MEN1KMT2A | |
| SCHEMBL13108365 | 0.83 | HSD17B10 (0.30) | — | |
| SCHEMBL13108367 | 0.83 | HSD17B10 (0.30) | — | |
| SCHEMBL1720558 | 0.82 | MEN1 (0.34) | CA2MEN1KMT2A | |
| SCHEMBL13191130 | 0.82 | MEN1 (0.34) | CA2MEN1KMT2A | |
| SCHEMBL8958953 | 0.82 | MEN1 (0.34) | CA2MEN1KMT2A | |
| Isopropyl Alcohol SCHEMBL17409555 | 0.80 | MEN1 (0.39) | CA2MEN1KMT2A | |
| Isopropyl Alcohol SCHEMBL8085515 | 0.80 | MEN1 (0.39) | CA2MEN1KMT2A | |
| SCHEMBL27966326 | 0.80 | CA2 (0.31) | CA2 | |
| SCHEMBL10494991 | 0.79 | PIK3CD (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411458-A1 | TRANSLOCATION CONTROL ELEMENTS, REPORTER CODES, AND FURTHER MEANS FOR TRANSLOCATION CONTROL FOR USE IN NANOPORE SEQUENCING | Roche Sequencing Solutions, Inc. | 2022-12-29 | — | — | US | disclosed |
| WO-2020236526-A1 | TRANSLOCATION CONTROL ELEMENTS, REPORTER CODES, AND FURTHER MEANS FOR TRANSLOCATION CONTROL FOR USE IN NANOPORE SEQUENCING | STRATOS GENOMICS, INC. (US) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411458-A1 | TRANSLOCATION CONTROL ELEMENTS, REPORTER CODES, AND FURTHER MEANS FOR TRANSLOCATION CONTROL FOR USE IN NANOPORE SEQUENCING | PHAX, DNTT, NSUN3 | CA2 3854/4885MEN1 489/4885KMT2A 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.